CVE 8.7 HIGH

Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication_CVE-2025-61940

8.7 / 10
HIGH
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

AI Analysis

Use of client-side authentication vulnerability in NMIS/BioDose V22.02 and previous versions

Basic Information

ID CVE-2025-61940
Source icscert
Published Dec 2, 2025 at 21:07
Modified Dec 2, 2025 at 21:39

Affected Product

Vendor Mirion Medical
Product EC2 Software NMIS BioDose
Affected Versions Mirion Medical EC2 Software NMIS BioDose 0

CWE Classification

AI Assessment

AI Score 8.7 / 10
AI Severity High
Vendor Mirion Medical
Product NMIS/BioDose
Version V22.02 and previous versions

References

💭 Join the Security Discussion

🔒 Your email address will not be published. Required fields are marked *

⚠️ Please be respectful and constructive in your comments. Security discussions should remain professional.